No black box warning on record for Multaq

As of the latest FDA labeling reviewed, Multaq (DRONEDARONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Multaq medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Determine cardiac rhythm at least once every 3 months. If AF is detected discontinue MULTAQ or cardiovert. ( 5.2 ) • Ensure appropriate antithrombotic therapy prior to and throughout MULTAQ use. ( 5.3 ) • Liver injury: If hepatic injury is suspected, discontinue MULTAQ. ( 5.5 ) • If pulmonary toxicity is confirmed, discontinue treatment. ( 5.6 ) • Hypokalemia and hypom

No black box warning on record for Multaq

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Determine cardiac rhythm at least once every 3 months. If AF is detected discontinue MULTAQ or cardiovert. ( 5.2 ) • Ensure appropriate antithrombotic therapy prior to and throughout MULTAQ use. ( 5.3 ) • Liver injury: If hepatic injury is suspected, discontinue MULTAQ. ( 5.5 ) • If pulmonary toxicity is confirmed, discontinue treatment. ( 5.6 ) • Hypokalemia and hypom

Multaq Black Box Warning

No black box warning on record for Multaq

Other warnings & precautions

Multaq Black Box Warning

No black box warning on record for Multaq

Other warnings & precautions